Upgrades
- Agios Pharmaceuticals (AGIO) upgraded by JPMorgan from Neutral to Overweight
- Agios Pharmaceuticals (AGIO) upgraded by Canaccord from Hold to Buy
- Endo (ENDP) upgraded by Mizuho from Underperform to Neutral
- Ferroglobe (GSM) upgraded by Jefferies from Hold to Buy
- Endologix (ELGX) upgraded by Canaccord from Hold to Buy
- NGL Energy Partners (NGL) upgraded by Wunderlich from Hold to Buy
- Aptose Biosciences (APTO) upgraded by Roth Capital from Neutral to Buy
- Estee Lauder (EL) upgraded by CLSA from Outperform to Buy
[ad#upgrades-336]
Downgrades
- Interxion (INXN) downgraded by Jefferies from Buy to Hold
- Baidu (BIDU) downgraded by Citi from Buy to Neutral
- Nord Anglia (NORD) downgraded by CLSA from Buy to Outperform
- Gulfport Energy (GPOR) downgraded by KLR Group from Buy to Accumulate
- Occidental Petroleum (OXY) downgraded by Morgan Stanley from Overweight to Equal Weight
- Occidental Petroleum (OXY) downgraded by Morgan Stanley from Overweight to Equal Weight
- Vodafone (VOD) downgraded by Macquarie from Outperform to Neutral
- Nord Anglia (NORD) downgraded by CLSA from Buy to Outperform
- Gulfport Energy (GPOR) downgraded by KLR Group from Buy to Accumulate
- SAP (SAP) downgraded by Jefferies from Hold to Underperform
[ad#ia-bret]
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of TheFly’s services FREE for 14 days by clicking here.